Oxycodone Kalceks (Oxycodone Hydrochloride)

Oxycodone Kalceks is an opioid analgesic that acts on the central nervous system to relieve pain.

• Acute postoperative pain: provides strong analgesia during the recovery period after surgery.
• Cancer‑related pain: helps control persistent pain associated with malignant disease.
• Severe chronic non‑cancer pain: reduces pain intensity when other treatments are insufficient.
• Pain from traumatic injuries: alleviates intense pain following major injuries such as fractures.
• Palliative care pain: improves comfort for patients with life‑limiting illnesses.

• Oxycodone binds to mu‑opioid receptors in the brain and spinal cord, activating inhibitory G‑protein pathways that decrease neuronal excitability and reduce the transmission of nociceptive signals. This receptor activation also modulates descending pain pathways, producing analgesia throughout the central nervous system.

Oxycodone Kalceks may cause a range of adverse reactions, from mild to potentially life‑threatening.

Common Side Effects

• Constipation: reduced bowel motility leading to hard stools.
• Nausea: feeling of queasiness, sometimes with vomiting.
• Drowsiness: increased sleepiness or fatigue.
• Dizziness: light‑headed sensation, especially when standing.
• Dry mouth: reduced salivary flow causing oral discomfort.
• Sweating: excessive perspiration without exertion.

Serious or Rare Side Effects

• Respiratory depression: slowed or shallow breathing that can be fatal.
• Severe hypotension: marked drop in blood pressure leading to fainting.
• Seizures: convulsive episodes, particularly in overdose.
• Allergic reactions: rash, itching, swelling, or anaphylaxis.
• Dependence and withdrawal: physical and psychological reliance with withdrawal symptoms on cessation.
• QT interval prolongation: cardiac rhythm disturbance that may cause arrhythmias.

When using Oxycodone Kalceks, careful assessment and monitoring are essential to minimise risks.

• Assess pain severity and treatment goals: ensure opioid therapy is appropriate.
• Evaluate patient history: screen for respiratory disorders, head injury, or substance abuse.
• Monitor for sedation and respiratory depression: especially during dose initiation and titration.
• Avoid concurrent CNS depressants: limit use of alcohol, benzodiazepines, or other opioids.
• Educate patients on safe use: emphasize adherence to prescribed dosing and storage.
• Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Oxycodone Kalceks can interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Benzodiazepines: combined use can cause profound respiratory depression and excessive sedation.
• Central nervous system depressants: concurrent alcohol or barbiturates markedly increase overdose risk.
• CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): can raise oxycodone plasma levels, heightening toxicity.

Moderate Interactions (Monitor Closely)

• CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may reduce conversion to active metabolites, affecting analgesia.
• Anticholinergic agents: can exacerbate constipation and urinary retention.
• Diuretics: may increase the risk of orthostatic hypotension when combined with opioid‑induced vasodilation.